Skip to content
Biodatica
Start free

JACOBIO PHARMACEUTICALS CO., LTD

Location not on file

OncologyPhase II
Compare Sign in to watch

What changed

Study registered, no phase assigned: The Impact of Physical Exercise on Working Memory in Elderly People With Mild Cognitive Impairment

5w agoTrial registeredJun 12, 2026Source filing (opens the source filing in a new tab)

Momentum

90no change

Momentum 90 out of 100, unchanged since the last recompute.

Accelerating: several high-weight events landed recently.

Runway (estimate)

—unknown

No disclosed raise on file, so there is nothing to model from.

Stage

Phase II

The furthest-along thing in the public record. Not a projection.

Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.

Peer position

1,843 pre-ticker oncology companies at Phase II

Peer ranking — where this company sits among its stage-and-area peers by momentum, and how its runway compares to the peer median — is part of the Analyst tier.

Compare seats

A ranking of the same momentum figure the feed publishes, computed live against public-filing peers. It is a relative position, not a recommendation, and it is identical for every viewer.

Grant to raise

Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.

  1. Trial

    NA registered

    Mar 4, 2026

    Mild Cognitive Impairment · ENROLLING_BY_INVITATION · sponsor: Shanghai University of Sport · The Impact of Physical Exercise on Working Memory in Elderly People With Mild Cognitive Impairment

    ClinicalTrials.gov · NCT07644156 (opens the source filing in a new tab)

  2. Trial

    PHASE2 registered

    Jan 19, 2026

    Hepato Cellular Carcinoma (HCC) · RECRUITING · sponsor: Fudan University · A Platform Trial for Personalized and Adaptive Therapies in Hepatocellular Carcinoma

    ClinicalTrials.gov · NCT07328009 (opens the source filing in a new tab)

  3. Trial

    PHASE2 registered

    Jul 2, 2025

    Hepatocellular Carcinoma (HCC) · RECRUITING · sponsor: Fudan University · Lenvatinib Plus Tislelizumab Versus Lenvatinib Alone in Hepatocellular Carcinoma Previously Treated With Anti-PD1/PD-L1 and Bevacizumab

    ClinicalTrials.gov · NCT07047586 (opens the source filing in a new tab)

  4. Patent

    Patent granted

    Jan 14, 2025

    assignee: JACOBIO PHARMACEUTICALS CO., LTD · KRAS mutant protein inhibitors

    USPTO · US 12195473 (opens the source filing in a new tab)

  5. Trial

    PHASE2 registered

    Sep 26, 2021

    Advanced Hepatocellular Carcinoma · RECRUITING · sponsor: Fudan University · Cryoablation Combined with Tislelizumab Plus Lenvatinib As Second-line or Later Therapy in Advanced Hepatocellular Carcinoma

    ClinicalTrials.gov · NCT05057845 (opens the source filing in a new tab)

  6. Trial

    PHASE2 registered

    Jul 7, 2020

    Intrahepatic Cholangiocarcinoma · RECRUITING · sponsor: Fudan University · Cryoablation Combined with Anti-PD-1 Antibody in Patients with Advanced Intrahepatic Cholangiocarcinoma

    ClinicalTrials.gov · NCT04299581 (opens the source filing in a new tab)

  7. Trial

    PHASE2 registered

    Dec 3, 2019

    Prostate Cancer Recurrent · COMPLETED · sponsor: Patrick Hensley · Hydroxychloroquine to Increase Tumor Suppressor PAR-4 Levels in Oligometastatic Prostate Cancer

    ClinicalTrials.gov · NCT04011410 (opens the source filing in a new tab)

  8. Trial

    Study registered

    Sep 1, 2019

    ILD OSA · RECRUITING · sponsor: Dan Liu · Interstitial Lung Disease and Obstructive Sleep Apnea

    ClinicalTrials.gov · NCT05838183 (opens the source filing in a new tab)

Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources